Testing effectiveness (Phase 2)Looking for participantsNCT05587894
What this trial is testing
OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial
Who this might be right for
COVID-19Immunodeficiency
ANRS, Emerging Infectious Diseases 256